DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy

The study highlighted the relevance of DNA methylation in shaping the constitutive immune classification of PM cells, independent of their histological subtypes. The identified role of DHA in shifting the phenotype of PM cells towards an immune-favorable state highlights its potential for evaluation in phase I/II clinical trials investigating the efficacy of epigenetic-based ICI combinations to reverse cancer immune resistance mechanisms.

Authors

Institutions

Publication Details

Journal
Journal of Experimental & Clinical Cancer Research
Published
2025-02-18
DOI
https://doi.org/10.1186/s13046-025-03310-0
Citations
2
Primary Topic
Occupational and environmental lung diseases
Type
article
Field-Weighted Citation Impact
3.04

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy

Andrea Anichini, Alessia Covre, Luana Calabrò, Michele Maio et al.
2 citations
Journal of Experimental & Clinical Cancer Research
Occupational and environmental lung diseases
3.04
article

DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy

Andrea Anichini, Alessia Covre, Luana Calabrò, Michele Maio, Rossella Tufano, Teresa Noviello, Francesca Piazzini, Fabrizio Celesti, Maria Fortunata Lofiego, Roberta Mortarini, Laura Solmonese, Francesco Marzani, Michele Ceccarelli, Francesca Pia Caruso, Sandra Coral, Anna Maria Di Giacomo, Emma Bello
article en
2 citations

Abstract

The study highlighted the relevance of DNA methylation in shaping the constitutive immune classification of PM cells, independent of their histological subtypes. The identified role of DHA in shifting the phenotype of PM cells towards an immune-favorable state highlights its potential for evaluation in phase I/II clinical trials investigating the efficacy of epigenetic-based ICI combinations to reverse cancer immune resistance mechanisms.

Journal of Experimental & Clinical Cancer ResearchVol. 44(1)
University of Siena (IT), University of Miami (US), University of Ferrara (IT), Biogem (IT), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), Sylvester Comprehensive Cancer Center (US), University of Naples Federico II (IT)
Ministero della Salute, Associazione Italiana per la Ricerca sul Cancro
Good health and well-being
Openalex Percentile: Top 11%
Occupational and environmental lung diseases
3.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.